Mylan v. Aurobindo: The Story Of A Pharma Preliminary Injunction
Last month, the Federal Circuit affirmed the district court’s granting of a preliminary injunction (PI) precluding Aurobindo from marketing its proposed isosulfan blue (ISB) product in the U.S. The district court originally based the PI on three…


